Jpmorgan Chase & CO Atri Cure, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATRC
# of Institutions
206Shares Held
48.3MCall Options Held
111KPut Options Held
23.8K-
Vanguard Group Inc Valley Forge, PA4.62MShares$156 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$155 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY4.2MShares$142 Million0.03% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.67MShares$90 Million0.39% of portfolio
-
Macquarie Group LTD Australia, C32MShares$67.3 Million0.05% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.56B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...